A_phase_I,_II_study_of_high-dose_5-fluorouracil_and_high-dose_leucovorin_with_low-dose_phosphonacetyl-L-aspartic_acid_in_patients_with_advanced_malignancies._Twenty-eight_patients_with_refractory_advanced_malignancies_were_treated_with_a_24-hour_infusion_of_5-fluorouracil_(5-FU),_leucovorin_(LV),_and_N-(phosphonacetyl)-L-aspartic_acid_(PALA)_weekly._Twenty-seven_patients_were_evaluable_to_assess_toxicity_and_antitumor_activity._The_PALA_was_administered_as_an_intravenous_bolus_over_15_minutes_at_a_fixed_dose_(250_mg/m2)_24_hours_before_the_start_of_the_5-FU_and_leucovorin_infusions._Initially_the_dose_of_5-FU_was_750_mg/m2;_this_was_increased_incrementally_to_2600_mg/m2._The_LV_was_administered_in_a_fixed_dose_of_500_mg/m2_concurrently_with_the_5-FU_over_a_24-hour_period._This_regimen_was_repeated_weekly._Diarrhea,_stomatitis,_nausea,_and_vomiting_were_among_the_dose-limiting_toxicities._Others_were_hand-foot_syndrome,_hair_loss_of_the_scalp_and_eyelashes,_overall_weakness,_rhinitis,_and_chemical_conjunctivitis._The_maximum_tolerated_dose_of_5-FU_in_this_combination_and_schedule_was_2600_mg/m2._Seven_of_14_patients_treated_with_2600_mg/m2_were_able_to_tolerate_the_chemotherapy_on_a_weekly_basis_without_interruption._The_other_seven_patients_required_dose_reductions,_but_most_received_5-FU_at_a_dose_of_2100_mg/m2._Twenty-three_of_27_patients_were_treated_previously._Eight_patients_had_a_partial_response;_five_of_these_were_treated_previously._A_complete_response_was_observed_in_one_patient_with_pancreatic_carcinoma,_previously_untreated._The_overall_response_rate_for_patients_treated_with_2100_or_2600_mg/m2_of_5-FU_was_nine_of_18_patients_(50%)._Three_of_four_previously_untreated_patients_with_pancreatic_cancer_responded_to_this_treatment_(two_responded_partially,_and_one_had_a_complete_response)._One_of_three_heavily_pretreated_patients_with_non-small_cell_lung_cancer_had_a_partial_response_as_did_a_patient_with_breast_cancer._Four_of_ten_patients_with_colorectal_cancer_responded_to_the_treatment_(four_partial_responses),_of_whom_three_had_been_treated_previously.